About Tien-Li Lee
Tien-Li Lee is a chief executive officer and director at Aardvark Therapeutics.
Tien-Li Lee reports to the SEC as a director, officer or major shareholder of 2 public companies, including Scilex Holding (SCLX).
Tien-Li Lee first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Tien-Li Lee in the role, so the role may have started earlier or lasted longer.
SC
Scilex Holding Co
Director
2022 – 2023 · Public company (SCLX)
Key Colleagues at Startups
The people Tien-Li Lee works with at each company, as listed on that company's latest Form D.
Aardvark Therapeutics, Inc. · Form D, May 15, 2024